Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.
Patrick Vizeli, Erich Studerus, Friederike Holze, Yasmin Schmid, Patrick C Dolder, Laura Ley, Isabelle Straumann, Anna M Becker, Felix Müller, Denis Arikci, Matthias E Liechti
Translational psychiatry September 4, 2024 DOI: 10.1038/s41398-024-03074-9 via PubMed
Summary
AI-generated from the abstractLSD dose is the strongest predictor of the drug's subjective and autonomic effects, but non-pharmacological factors also play a significant role. Pre-drug mood states—such as well-being, emotional excitability, and anxiety—predict subjective effects, heart rate, and body temperature. The personality trait openness to experiences correlates with stronger mystical-type effects and oceanic boundlessness. Prior hallucinogen use is linked to less anxious ego dissolution and a less intense overall altered state. Acute anxiety relates negatively to the functionality of the Cytochrome 2D6 enzyme. Sex and body weight do not significantly influence the drug experience.
Study at a glance
| Characteristics | Analysis of nine double-blind, placebo-controlled, cross-over studies Peer reviewed |
|---|---|
| Sample size | 213 |
| Population | Healthy human subjects |
| Intervention | LSD |
| Dose | 25-200 µg |
| Keywords | Personality psychology Psychopharmacology Mental states Psychedelics Neuroscience |
| Citations | 15 |
| Key finding | LSD dose, pre-drug mood states, openness to experiences, and prior hallucinogen use significantly predict subjective and autonomic responses to LSD, while sex and body weight do not. |
Abstract
The pharmacodynamic effects of lysergic acid diethylamide (LSD) are diverse and different in different individuals. Effects of other psychoactive substances have been shown to be critically influenced by non-pharmacological factors such as personality traits and mood states. The aim of this study was to determine pharmacological and psychological predictors of the LSD effects in healthy human subjects. This analysis is based on nine double-blind, placebo-controlled, cross-over studies with a total of 213 healthy subjects receiving between 25-200 µg LSD. The influence of sex, age, dose, body weight, pharmacogenetic, drug experience, personality, setting, and mood before drug intake on the peak autonomic and total subjective responses to LSD was investigated using multiple linear mixed effects models and Least Absolute Shrinkage and Selection Operator regression. Results were adjusted for LSD dose and corrected for multiple testing. LSD dose emerged as the most influential predictor, exhibiting a positive correlation with most response variables. Pre-drug mental states such as "Well-Being", "Emotional Excitability", and "Anxiety" were also important predictor for a range of subjective effects but also heart rate and body temperature. The trait "Openness to Experiences" was positively correlated with elevated ratings in "Oceanic Boundlessness" and mystical-type effects. Previous experiences with hallucinogens have been negatively associated with the overall altered state of consciousness and particularly with "Anxious Ego Dissolution". Acute anxiety negatively correlated with the genetically determined functionality of the Cytochrome 2D6 enzyme. In summary, besides the amount of drug consumed, non-pharmacological factors such as personal traits and current mood also significantly predicted the subjective drug experience. Sex and body weight were not significant factors in influencing the drug experience.